128 related articles for article (PubMed ID: 37187223)
1. Macro-GH - A clinical entity causing a diagnostic challenge - A case report.
Stelmachowska-Banaś M; Ostrowska M; Goszczyński TM; Kowalski K; Korbonits M; Kapuścińska R; Zgliczyński W; Glinicki P
Clin Chim Acta; 2023 Jun; 546():117392. PubMed ID: 37187223
[TBL] [Abstract][Full Text] [Related]
2. Acromegaly with initial negative oral glucose tolerance test: a case report.
Tsai WH; Chien MN; Dai SH; Chan YK
J Med Case Rep; 2023 Aug; 17(1):333. PubMed ID: 37543629
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
Freda PU; Post KD; Powell JS; Wardlaw SL
J Clin Endocrinol Metab; 1998 Nov; 83(11):3808-16. PubMed ID: 9814451
[TBL] [Abstract][Full Text] [Related]
4. Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients.
De Marinis L; Mancini A; Bianchi A; Gentilella R; Valle D; Giampietro A; Zuppi P; Anile C; Maira G; Giustina A
Metabolism; 2002 May; 51(5):616-21. PubMed ID: 11979395
[TBL] [Abstract][Full Text] [Related]
5. The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly.
Carmichael JD; Bonert VS; Mirocha JM; Melmed S
J Clin Endocrinol Metab; 2009 Feb; 94(2):523-7. PubMed ID: 19033371
[TBL] [Abstract][Full Text] [Related]
6. Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings.
Tamanini JVG; Dal Fabbro M; de Freitas LLL; Vassallo J; de Souza Queiroz L; Rogerio F
Neurosurg Focus; 2020 Jun; 48(6):E12. PubMed ID: 32480373
[TBL] [Abstract][Full Text] [Related]
7. Reliability of the oral glucose tolerance test in the early postoperative assessment of acromegaly remission.
Kristof RA; Neuloh G; Redel L; Klingmüller D; Schramm J
J Neurosurg; 2002 Dec; 97(6):1282-6. PubMed ID: 12507124
[TBL] [Abstract][Full Text] [Related]
8. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
Cardinal T; Rutkowski MJ; Micko A; Shiroishi M; Jason Liu CS; Wrobel B; Carmichael J; Zada G
Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366
[TBL] [Abstract][Full Text] [Related]
9. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly.
Biermasz NR; van Dulken H; Roelfsema F
J Clin Endocrinol Metab; 2000 Dec; 85(12):4596-602. PubMed ID: 11134114
[TBL] [Abstract][Full Text] [Related]
10. Caloric restriction as a possible pitfall for persistent acromegaly follow-up - case report.
Martins AF; Santos M; Rosário F
BMC Endocr Disord; 2023 Mar; 23(1):68. PubMed ID: 36973824
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of acromegaly in a patient with type 1 diabetes mellitus.
Hofmann EA; Polonsky KS; Weiss RE
Endocr Pract; 2002; 8(2):113-8. PubMed ID: 11942776
[TBL] [Abstract][Full Text] [Related]
12. Clinical, hormonal and magnetic resonance imaging (MRI) predictors of transsphenoidal surgery outcome in acromegaly.
Bourdelot A; Coste J; Hazebroucq V; Gaillard S; Cazabat L; Bertagna X; Bertherat J
Eur J Endocrinol; 2004 Jun; 150(6):763-71. PubMed ID: 15191345
[TBL] [Abstract][Full Text] [Related]
13. Transsphenoidal surgery for acromegaly: predicting remission with early postoperative growth hormone assays.
Sarkar S; Jacob KS; Pratheesh R; Chacko AG
Acta Neurochir (Wien); 2014 Jul; 156(7):1379-87; discussion 1387. PubMed ID: 24781680
[TBL] [Abstract][Full Text] [Related]
14. Value of early postoperative random growth hormone levels and nadir growth hormone levels after oral glucose tolerance testing in acromegaly.
Rotermund R; Burkhardt T; Rohani Z; Jung R; Aberle J; Flitsch J
Growth Horm IGF Res; 2018 Aug; 41():64-70. PubMed ID: 29555234
[TBL] [Abstract][Full Text] [Related]
15. Improvement of insulin resistance following transsphenoidal surgery in patients with acromegaly: correlation with serum IGF-I levels.
Mori K; Iwasaki Y; Kawasaki-Ogita Y; Honjo S; Hamamoto Y; Tatsuoka H; Fujimoto K; Ikeda H; Wada Y; Takahashi Y; Takahashi J; Koshiyama H
J Endocrinol Invest; 2013 Nov; 36(10):853-9. PubMed ID: 23665535
[TBL] [Abstract][Full Text] [Related]
16. Clinically silent somatotropinomas may be biochemically active.
Sakharova AA; Dimaraki EV; Chandler WF; Barkan AL
J Clin Endocrinol Metab; 2005 Apr; 90(4):2117-21. PubMed ID: 15671111
[TBL] [Abstract][Full Text] [Related]
17. Delayed diagnosis of acromegaly in a patient with focal segmental Glomerulosclerosis: a rare case report and literature review.
Zheng J; Cui Z; Lv JC; Duan HZ; Wang SX; Zhang JQ; Zhou FD; Guo XH; Zhao MH
BMC Nephrol; 2019 Nov; 20(1):435. PubMed ID: 31771524
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A
J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
[TBL] [Abstract][Full Text] [Related]
19. Decrease of Serum IGF-I following Transsphenoidal Pituitary Surgery for Acromegaly.
Yu M; Bruns DE; Jane JA; Nass RM; Oldfield EH; Vance ML; Thorner MO
Clin Chem; 2017 Feb; 63(2):486-494. PubMed ID: 27974387
[TBL] [Abstract][Full Text] [Related]
20. Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria.
Hazer DB; Işık S; Berker D; Güler S; Gürlek A; Yücel T; Berker M
J Neurosurg; 2013 Dec; 119(6):1467-77. PubMed ID: 24074496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]